Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
| ▸ | MITF | O75030 | 1/20 | 0.34 |
| ▸ | IDE | P14735 | 2/20 | 0.33 |
| ▸ | APAF1 | O14727 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.32 |
| ▸ | UBE2N | P61088 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7023461 | 0.87 | TAAR1 (0.48) | TAAR1MITFIDEAPAF1L3MBTL1 | |
| SCHEMBL4022695 | 0.83 | TAAR1 (0.38) | TAAR1MITFIDEAPAF1L3MBTL1 | |
| SCHEMBL27911335 | 0.82 | TAAR1 (0.54) | TAAR1CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31397702 | 0.82 | TAAR1 (0.45) | TAAR1MITFIDEAPAF1L3MBTL1 | |
| SCHEMBL6162404 | 0.81 | TAAR1 (0.37) | TAAR1MITFIDEAPAF1L3MBTL1 | |
| SCHEMBL3110597 | 0.81 | TAAR1 (0.43) | TAAR1MITFIDEAPAF1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL28058920 | 0.79 | TAAR1 (0.42) | TAAR1MITFIDEAPAF1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL28058916 | 0.79 | TAAR1 (0.42) | TAAR1MITFIDEAPAF1L3MBTL1 | |
| SCHEMBL7018057 | 0.79 | TAAR1 (0.58) | TAAR1CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11288313 | 0.78 | TAAR1 (0.54) | TAAR1TDP1CYP2D6SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3305784-A1 | HAPTENS OF QUETIAPINE FOR USE IN IMMUNOASSAYS | Janssen Pharmaceutica NV (BE) | 2018-04-11 | — | — | EP | disclosed |